论文部分内容阅读
本文观察吸入型糖皮质激素加长效β2受体激动剂(舒利迭)对中、重度慢性阻塞性肺疾病(COPD)的疗效。
This article observed the inhaled glucocorticoid plus long-acting β 2 receptor agonist (Seretide) on moderate and severe chronic obstructive pulmonary disease (COPD) curative effect.